13 | Liposomes (Liposome)IBA
12/2019
-
03/2009 |
11 | Folic Acid (Vitamin M)FDA LinkGeneric
12/2019
-
10/2006 |
10 | Pharmaceutical PreparationsIBA
11/2021
-
11/2012 |
9 | Cisplatin (Platino)FDA LinkGeneric
08/2021
-
04/2014 |
7 | LipidsIBA
01/2021
-
03/2009 |
6 | LigandsIBA
01/2020
-
01/2014 |
5 | Doxorubicin (Adriamycin)FDA LinkGeneric
09/2018
-
01/2014 |
4 | Glutathione (Reduced Glutathione)IBA
08/2021
-
01/2018 |
4 | IronIBA
01/2021
-
01/2018 |
4 | Small Interfering RNA (siRNA)IBA
12/2019
-
01/2014 |
3 | Hydroxyl RadicalIBA
01/2021
-
10/2020 |
3 | CurcuminIBA
06/2020
-
02/2016 |
3 | Silicon Dioxide (Silica)FDA LinkGeneric
01/2020
-
10/2017 |
3 | Calcium Carbonate (Limestone)FDA Link
01/2019
-
11/2017 |
3 | Chelating AgentsIBA
10/2018
-
07/2016 |
3 | VaccinesIBA
01/2018
-
01/2016 |
2 | Lipase (Acid Lipase)FDA Link
11/2021
-
01/2021 |
2 | MicellesIBA
08/2021
-
02/2016 |
2 | AcidsIBA
01/2021
-
07/2017 |
2 | Oleanolic AcidIBA
01/2019
-
07/2017 |
2 | di-n-butyltin (dibutyltin)IBA
04/2014
-
02/2012 |
2 | liposomal doxorubicin (Doxil)FDA Link
04/2013
-
09/2007 |
1 | Proteolysis Targeting ChimeraIBA
12/2022 |
1 | pomalidomideIBA
12/2022 |
1 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2021 |
1 | CollagenIBA
11/2021 |
1 | Cytidine Triphosphate (CTP)IBA
08/2021 |
1 | benzeneboronic acidIBA
08/2021 |
1 | Multidrug Resistance-Associated Protein 2IBA
08/2021 |
1 | Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2021 |
1 | Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2021 |
1 | Glucose OxidaseIBA
01/2021 |
1 | Oleic Acid (Oleate)IBA
01/2021 |
1 | IonsIBA
01/2021 |
1 | calcium peroxideIBA
01/2021 |
1 | Reactive Oxygen Species (Oxygen Radicals)IBA
10/2020 |
1 | Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2020 |
1 | PeroxidesIBA
10/2020 |
1 | Ado-Trastuzumab EmtansineIBA
09/2020 |
1 | Brentuximab VedotinIBA
09/2020 |
1 | Inotuzumab OzogamicinIBA
09/2020 |
1 | polatuzumab vedotinIBA
09/2020 |
1 | Gemtuzumab (Mylotarg)FDA Link
09/2020 |
1 | PlatinumIBA
06/2020 |
1 | AcriflavineIBA
01/2020 |
1 | Ursolic AcidIBA
12/2019 |
1 | Biological ProductsIBA
12/2019 |
1 | Proteins (Proteins, Gene)FDA Link
12/2019 |
1 | phosphonic acidIBA
10/2018 |
1 | Integrin alpha4beta1 (VLA-4)IBA
10/2018 |
1 | Gallium-68IBA
10/2018 |
1 | Therapeutic UsesIBA
10/2018 |
1 | NanocapsulesIBA
10/2018 |
1 | 2,2- (7- (3- (3- hydroxy- 2- oxopyridin- 1(2H)- yl)propyl)- 1,4,7- triazonane- 1,4- diyl)diacetic acidIBA
01/2018 |
1 | Sorafenib (BAY 43-9006)FDA Link
01/2018 |
1 | Pentetic Acid (DTPA)FDA LinkGeneric
01/2018 |
1 | LipofectamineIBA
01/2018 |
1 | 2,2- (7- (2- (3- hydroxy- 2- oxopyridin- 1(2H)- yl)ethyl)- 1,4,7- triazonane- 1,4- diyl)diacetic acidIBA
01/2018 |
1 | MetalsIBA
01/2018 |
1 | 1,4,7-triazacyclononaneIBA
01/2018 |
1 | 20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
07/2017 |
1 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
07/2017 |
1 | HexokinaseIBA
01/2017 |
1 | BenserazideIBA
01/2017 |
1 | Antineoplastic Agents (Antineoplastics)IBA
01/2017 |
1 | AntibodiesIBA
01/2017 |
1 | Immunoconjugates (Immunoconjugate)IBA
01/2017 |
1 | Immunoglobulin G (IgG)IBA
01/2017 |
1 | RadiopharmaceuticalsIBA
07/2016 |
1 | peptide SVYDFFVWLIBA
02/2016 |
1 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
02/2016 |
1 | sigma-2 receptorIBA
01/2016 |
1 | AntigensIBA
01/2016 |
1 | Benzoates (Benzoate)IBA
04/2014 |
1 | Imatinib Mesylate (Gleevec)FDA Link
01/2014 |
1 | Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2014 |
1 | Blood Proteins (Serum Proteins)IBA
01/2014 |